The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food ...

A U.S. Federal Claims Court judge shot down Vanda Pharmaceuticals Inc.’s accusations that the FDA disclosed the company’s trade secrets to generic competitors, finding that the trade secrets weren’t ...

With California wildfires triggering a massive rebuilding process that could take several years, investors are looking closer at lumber stocks.

Begin your TipRanks Premium journey today. Vanda (VNDA) Company Description: Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs.

Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Motion Sickness. According to GlobalData, Phase III drugs for Motion Sickness have a 100% phase ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

submitted by Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) for Tradipitant for symptoms in gastroparesis. The notice offers Vanda an opportunity to request a hearing on the matter. Also Read ...